Abris, this was a fascinating read — especially the section on statins. I’ve been on a statin for years, and I do take CoQ10 because I’ve always known there was some connection there, but I’ve never seen the mechanisms laid out this clearly. The contrast you draw is striking: the same clinicians who warn about “unpredictable” effects from nattokinase are often prescribing a drug that very predictably alters multiple points in the coagulation pathway and depletes CoQ10 as part of its basic mechanism.

I’m not taking a position on nattokinase here — that’s a conversation for a qualified clinician — but I appreciate the reminder that every intervention, pharmaceutical or otherwise, has a biological footprint. And for those of us who’ve been on statins long-term, understanding the CoQ10 angle and the broader mitochondrial story is genuinely useful context to bring into a medical discussion.

As always, the value in pieces like this is the clarity: knowing what questions to ask, what tradeoffs to understand, and how to have a more informed conversation with your doctor rather than a passive one.